SERPINA1 and fatty liver disease: In total, PR3, NE and AAT plasma concentrations were measured and compared in four groups: 1) lean healthy control group, 2) obese (without steatosis) control group, 3) liver steatosis group and 4) type 2 diabetes group (T2DM).